Clinical study cutaneous and labyrinthine tolerance of bioactive glass s53p4 in mastoid and epitympanic obliteration surgery: prospective clinical study

HIGHLIGHTS

• who: Daniele Bernardeschi and colleagues from the Implants Auditifs et Chirurgie de Base du Crâne, Paris, France have published the article: Clinical Study Cutaneous and Labyrinthine Tolerance of Bioactive Glass S53P4 in Mastoid and Epitympanic Obliteration Surgery: Prospective Clinical Study, in the Journal: (JOURNAL) of 22/05/2015
• what: The aim of this prospective observational uncontrolled study was to assess the cutaneous (retroauricular and the external auditory canal) and inner ear tolerance of the BG S53P4 when used for obliteration of canal-wall-down (CWD) and canal-wall-up (CWU) mastoidectomies.

SUMMARY . . .

 

If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.